Abstract
In PLoS Medicine, volume 3, issue 8: DOI: 10.1371/journal.pmed.0030330 Reference 13 was mistakenly not cited in the main article. It should have been added as a reference to the sentence: “Claims associated with costs of drug development merit careful scrutiny since they are often used as a rhetorical tool to argue for faster approval times or to justify the high price of pharmaceuticals [13].”
Highlights
Minnehy Mukoma should have been included in the Acknowledgments for research design and implementation
In PLoS Medicine, volume 3, issue 8: Under the section heading “Expected Death Toll during a Present-Day Mass Vaccination Campaign,” the numbers of expected deaths that were computed for a mass vaccination campaign were displayed as per million; they should be absolute numbers
The corrected text should be: “Under those assumptions, in the Netherlands mass vaccination with NYCBH would lead to 9.8 deaths, mass vaccination with Lister to 55.1 deaths, and mass vaccination with Bern would lead to 303.5 deaths
Summary
In PLoS Medicine, volume 3, issue 7: Table 3 should have listed Age (years) as Mean: 28.5, SD: 8.3 (not Mean: 8.3, SD: 9.6). Minnehy Mukoma should have been included in the Acknowledgments for research design and implementation.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
